CAS: 2241039-81-4
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Londamocitinib REF: 54-BUP05108CAS: 2241039-81-4 | 99.47% | 1.226,00 €~2.122,00 € | Mar 22 Abr 25 |
 | JAK1-IN-7 REF: 3D-RPD03981CAS: 2241039-81-4 | Min. 95% | A consultar | Lun 02 Jun 25 |
 | Londamocitinib REF: TM-T11706CAS: 2241039-81-4 | 99.47% | 180,00 €~1.568,00 € | Lun 21 Jul 25 |
Ref: 54-BUP05108
| 25mg | 1.226,00 € | ||
| 50mg | 1.582,00 € | ||
| 100mg | 2.122,00 € |
Entrega estimada en Estados Unidos, el Martes 22 de Abril de 2025
JAK1-IN-7
CAS:2241039-81-4
Please enquire for more information about JAK1-IN-7 including the price, delivery time and more detailed …
Fórmula:
C28H31F2N7O4S
Pureza:
Min. 95%
Peso molecular:
599.7 g/mol
Ref: 3D-RPD03981
| 5mg | 1.524,00 € | ||
| 10mg | 2.375,00 € | ||
| 25mg | 4.453,00 € | ||
| 50mg | 7.125,00 € |
Entrega estimada en Estados Unidos, el Lunes 2 de Junio de 2025
Londamocitinib
CAS:2241039-81-4
Londamocitinib (JAK1-IN-7) is a selective and potent JAK1 inhibitor with anti-inflammatory activity.
Fórmula:
C28H31F2N7O4S
Pureza:
99.47%
Forma y color:
Solid
Peso molecular:
599.65
Ref: TM-T11706
| 1mg | 180,00 € | ||
| 5mg | 439,00 € | ||
| 10mg | 597,00 € | ||
| 25mg | 905,00 € | ||
| 50mg | 1.169,00 € | ||
| 100mg | 1.568,00 € | ||
| 1mL*10mM (DMSO) | 567,00 € |
Entrega estimada en Estados Unidos, el Lunes 21 de Julio de 2025
